Dumb Money Live

Financial Meltdown — How to prepare

Today on Dumb Money, our stocks picks for companies that are immune to AI disruption.

Bud Light Boycott

Today on Dumb Money, how we find our best stock picks by watching insane TokTok trends like "BORG" the Black Out Rage Gallon.

Today on Dumb Money, how we're playing the banking crisis. Hint: we bought a bank.

Today on Dumb Money, what we found out about the Tesla robot while researching one of their humanoid robotics competitors.

Alan's Book: https://amzn.to/3lNrdth Audible: https://amzn.to/3XVABbR Today on Dumb Money, meet Alan Patricof, a wall street legend who has been investing in startups since before "venture capital" was even a thing.

Today on Dumb Money, our best stock pick last year is up 100%. Is it time to sell!?

Today on Dumb Money, the highly anticipated (and briefly leaked) "New Bing" is expected to be made official on February 7. What does it mean for $MSFT and $GOOG stock?

Today on Dumb Money, we're exploring the best nontraditional investments with Rob Petrozzo, the founder and CEO of Rally. Rally is an online platform that allows people to invest in and trade shares of rare and unique assets such as collectible cars, watches, and other luxury items.

Today on Dumb Money, we're prepping for the Fed on Wednesday and "triple A" earnings form Apple, Alphabet and Amazon on Thursday. But will reduced consumers cutting back on spending kill the rally we've seen so far in 2023?

Today on Dumb Money, the AI revolution has been underway for some time, but the introduction of OpenAI and ChatGPT is taking things to the next level. OpenAI and ChatGPT are two powerful tools that are giving companies the ability to automate processes, create more efficient customer service, and access a wealth of data quickly and accurately. These technologies are already being used by major tec...

The FDA is expected to approve Tirzepatide for weight loss sometime this year and we think it could become the best selling drug of ALL TIME. Today on Dumb Money, we'll weigh the data, size-up the opportunity, and give you the skinny on our diet drug investment thesis. Here are the GLP-1 RA drug makers and their drugs: Eli Lilly (ticker LLY) Tirzepatide sold as Mounjaro for diabetes. Weight loss v...

Today's FTX bankruptcy filing reveals new information and we reveal the real reason we said "no" to SBF and FTX.

Today on Dumb Money, we're picking stocks that should benefit from an unusually cold winter. Bundle up!

Today on Dumb Money, how we are playing the crypto collapse.

We hate the company but kinda love the stock. Today on Dumb Money, we'll decide if we're investing before earnings.

Today on Dumb Money, we reveal TWO huge apparel trends and the ONE company we're investing in.

Today on Dumb Money, how we're preparing for the worst. We'll catch up on our latest stock plays and answer your questions.

We're back! Did we miss anything? Today on Dumb Money, it's a live chat happy hour edition.

Last week's #BamaRushTok featured a bunch of must-have brands for 2022. Today on Dumb Money, we're going shopping and revealing our STOCK PICKS that could get a boost from the TikTok hype.

Today on Dumb Money, why we think this stock could have a 40X return.

Today on Dumb Money, what we're doing… the moves we're making. And a little historic perspective from 3 dudes who have been through our share of bear markets.

Today on Dumb Money, an Investing hack that will blow your mind: 5 magic words to uncover investable trends.

Our deep dive on Crocs stock and their acquisition of HeyDudes.